(19)
(11) EP 1 691 797 A2

(12)

(88) Date of publication A3:
18.05.2006

(43) Date of publication:
23.08.2006 Bulletin 2006/34

(21) Application number: 04795797.2

(22) Date of filing: 21.10.2004
(51) International Patent Classification (IPC): 
A61K 31/19(2006.01)
A61K 31/42(2006.01)
A61K 31/35(2006.01)
A61K 31/415(2006.01)
A61K 31/425(2006.01)
(86) International application number:
PCT/US2004/034685
(87) International publication number:
WO 2005/041864 (12.05.2005 Gazette 2005/19)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 21.10.2003 US 513099 P

(71) Applicant: Pharmacia Corporation
St. Louis, MO 63017-1732 (US)

(72) Inventor:
  • SMITH, Walter, G.
    St. Louis, MO 63122 (US)

(74) Representative: Dekker, Henrike Cornelie Christine et al
Pfizer European Pharma Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)

   


(54) COMBINATION OF CYCLOOXYGENASE-2 INHIBITOR AND PHOSPHODIESTERASE 4 INHIBITOR AND METHOD